Skip to main content
. 2009 Oct 26;54(1):360–366. doi: 10.1128/AAC.00771-09

TABLE 1.

Baseline characteristics of the study participants by pregnancy status and treatment allocation

Parameter Valuea
Pregnant
Nonpregnant
AZI-CQ (n = 15) AZI-SP (n = 14) AZI-CQ (n = 14) AZI-SP (n = 15)
Age (yr) 26.9 ± 4.1 23.9 ± 5.1 25.7 ± 5.8 27 ± 6.5
Wt (kg) 53.5 ± 7.1b 56.4 ± 7.9a 51.4 ± 5.4 51.9 ± 4.9
Height (cm) 154 ± 7.4 154 ± 7.3 154 ± 6.4 154 ± 2.8
Axillary temp (°C) 36.4 ± 0.7 36.5 ± 0.6 36.7 ± 0.3 36.4 ± 0.3
P. falciparum parasitemia 3 (20) 3 (21) 1 (7) 0 (0)
P. vivax parasitemia 1 (7) 0 (0) 0 (0) 1 (7)
Gestational age (wk) 24 [22-27] 21 [19-24]
Gravidity 3 [2-5] 2 [1-4] 1 [0-3] 2 [0-3]
Parity 2 [1-4] 1 [0-2] 0 [0-3] 1 [0-3]
Respiratory rate (/min) 20 ± 1 22 ± 5 20 ± 2 20 ± 1
Supine pulse rate (/min) 91 ± 10 89 ± 7 82 ± 10 88 ± 7
Supine MAP (mm Hg)c 78 ± 7 81 ± 10 79 ± 9 82 ± 7
Hemoglobin (g/dl) 8.5 ± 1.6b 8.2 ± 1.2b 9.3 ± 1.9 10 ± 1.3
Blood glucose (mmol/liter) 5.9 ± 1.6 5.7 ± 0.8 6.2 ± 1.1 5.6 ± 2.7
a

Data are mean ± SD, median [IQR], or number (%).

b

P < 0.05 versus nonpregnant subjects.

c

Mean arterial pressure, calculated by adding 1/3 of the pulse pressure (systolic minus diastolic pressure) to the diastolic pressure.